Chapter 4 Katherine Aragon and Matthew J. Gonzales Nausea is an unpleasant sensation that usually precedes vomiting. Nausea and vomiting are common in patients with serious illness, with almost three-quarters of patients admitted to a palliative care unit reporting it [1]. It is common in many end-stage diseases: 60% of advanced cancer patients, 43% of AIDS patients, 30% of end-stage renal disease patients, and 17% of heart failure patients [1, 2]. These symptoms are distressing for patients and families. Nausea and vomiting can lead to dehydration, electrolyte imbalances, and weight loss. Quick diagnosis and treatment can greatly improve these symptoms. In this chapter, we will detail a mechanism-based approach to the evaluation and management of nausea and vomiting. When exposed to a noxious stimulus, neuroreceptors activate one or more of the following four pathways: the cortex, the vestibular system, the chemoreceptor trigger zone (CTZ), or the receptors located in gastrointestinal (GI) tract. These pathways trigger the vomiting center located in the brain stem, which activates parasympathetic and motor-efferent nerves inducing vomiting [1, 3]. While research in this area is limited, small studies have shown a mechanism-based approach, where the initial antiemetic agent is selected according to the most likely causative pathway, to be 80–90% effective in the palliative care population [4, 5]. An alternative strategy is an empiric approach starting with a dopamine antagonist regardless of the underlying etiology [6]. We prefer a mechanism-based approach as it allows for systematic workup and targeted management and minimizes polypharmacy. Table 4.1 summarizes this approach, which is described in detail later. Table 4.1 Mechanism-Based Approach to Initial Management of Nausea and Vomiting A thorough history and examination is essential in elucidating the cause of nausea and/or vomiting. In over two-thirds of seriously ill patients, one or more causes will be determined [2]. History should focus on onset, frequency, and severity of nausea, recent medications, underlying medical illnesses, and associated symptoms. Ask about recent initiation or titration of opioids as commonly associated with nausea. Inquire about gastritis, reflux disease, and constipation as appropriate treatment may relieve symptoms. For cancer patients, find out the type of cancer, location of tumor(s), and any recent chemotherapy or radiotherapy. Key questions can help lead to determining the activated pathway. Early satiety, bloating, and relief of nausea with small-volume emesis are suggestive of gastric stasis. Alternatively, gastric obstruction is associated with colicky abdominal pain and large-volume bilious emesis. Nausea associated with certain smells or the sight of food suggests activation of the CTZ in the brain. Motion-induced nausea, often associated with vertigo indicates vestibular activation. Increased intracranial pressure typically causes early morning nausea and is associated with headaches and impaired cognition. Finally, anxiety or emotionally induced nausea suggests a cortical component [2, 7]. Physical examination should be attuned to confirming the pathway identified in the history. GI causes can be confirmed by evidence of ascites, enlarged liver, palpable abdominal mass, or impacted stool on rectal exam. Look for fever, confusion, asterixis, or neurological signs. Evidence of dehydration or weight loss may suggest symptom severity. Laboratory tests may not be necessary on all patients with nausea and vomiting. A basic metabolic panel may show evidence of a reversible cause as detailed in Table 4.2 requiring appropriate medical management. A plain abdominal radiograph can help distinguish between constipation and obstruction. For patients near the end of life, it may be appropriate to treat symptomatically without additional laboratory or radiological testing depending on the goals of care. Table 4.2 Reversible Causes of Nausea and Vomiting According to a mechanism-based model, initial antiemetic should be effective against the most likely neuroreceptor involved. In the hospital setting, severe nausea and vomiting require initiation of an IV antiemetic. The chosen antiemetic should be prescribed around the clock and titrated to the maximum recommended dose until relief is achieved. If symptoms persist, add another agent directed against a different receptor [1, 3, 8]. Once nausea is controlled, transition patients to an oral formulation. Many patients will require antiemetics on discharge for chronic symptoms. Nonpharmacological approaches to nausea and vomiting may be of benefit in addition to antiemetics. For chemotherapy-induced nausea, acupuncture and acupressure are beneficial [9]. More feasible options in the hospital setting include small meals, carbonated drinks, and avoidance of strong odors [8]. A small study of an inpatient palliative care unit found that the majority of nausea symptoms were caused by gastric stasis/outlet obstruction (35%) and chemical/metabolic disturbances (30%), primarily opioids [5]. A study of causes of nausea in hospice patients was similar: 44% were caused by impaired gastric emptying, 33% by chemical disturbance, and 19% by bowel obstruction [4]. In both studies, anxiety, increased intracranial pressure, and vestibular conditions made up only a few cases. Table 4.3 reviews common syndromes causing nausea/vomiting in seriously ill patients and their associated history and exam findings, specific causes, mechanism, and recommended treatment. These are detailed later (Table 4.4). Table 4.3 Common Causes of Nausea/Vomiting in Seriously Ill Patients
Nausea and Vomiting: Evaluation and Management in Hospitalized Patients
4.1 PATHOPHYSIOLOGY
4.2 MANAGEMENT
4.2.1 Evaluation
Causes
Management
4.2.2 Treatment
4.2.3 Alternative Treatments
4.3 APPROACH TO COMMON CAUSES
Clinical Syndrome
History and Exam Findings
Specific Causes
Associated Pathway
Antiemetics of Choice
Gastric stasis/impaired gastric emptying
History
Exam
Chemical/metabolic disturbances
History
Exam
Malignant bowel obstruction
History
Exam
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access